Canada
· Delayed Price · Currency is CAD ZYUS Life Sciences Statistics
Total Valuation
TSXV:ZYUS has a market cap or net worth of CAD 52.05 million. The enterprise value is 62.31 million.
| Market Cap | 52.05M |
| Enterprise Value | 62.31M |
Important Dates
The last earnings date was Thursday, May 8, 2025.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:ZYUS has 74.36 million shares outstanding. The number of shares has increased by 28.41% in one year.
| Current Share Class | 74.36M |
| Shares Outstanding | 74.36M |
| Shares Change (YoY) | +28.41% |
| Shares Change (QoQ) | +3.04% |
| Owned by Insiders (%) | 53.75% |
| Owned by Institutions (%) | 0.21% |
| Float | 32.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 108.21 |
| PB Ratio | -9.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.84 |
| EV / Sales | 129.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.28 |
Financial Position
The company has a current ratio of 0.19
| Current Ratio | 0.19 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.23 |
| Interest Coverage | -20.91 |
Financial Efficiency
Return on equity (ROE) is -380.47% and return on invested capital (ROIC) is -49.67%.
| Return on Equity (ROE) | -380.47% |
| Return on Assets (ROA) | -35.05% |
| Return on Invested Capital (ROIC) | -49.67% |
| Return on Capital Employed (ROCE) | 583.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 1.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.04% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -36.04% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 0.84 |
| Relative Strength Index (RSI) | 23.33 |
| Average Volume (20 Days) | 6,865 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSXV:ZYUS had revenue of CAD 481,000 and -33.81 million in losses. Loss per share was -0.47.
| Revenue | 481,000 |
| Gross Profit | -959,000 |
| Operating Income | -15.79M |
| Pretax Income | -35.89M |
| Net Income | -33.81M |
| EBITDA | -13.29M |
| EBIT | -15.79M |
| Loss Per Share | -0.47 |
Balance Sheet
The company has 1.90 million in cash and 12.16 million in debt, giving a net cash position of -10.26 million or -0.14 per share.
| Cash & Cash Equivalents | 1.90M |
| Total Debt | 12.16M |
| Net Cash | -10.26M |
| Net Cash Per Share | -0.14 |
| Equity (Book Value) | -5.34M |
| Book Value Per Share | -0.07 |
| Working Capital | -14.02M |
Cash Flow
In the last 12 months, operating cash flow was -9.88 million and capital expenditures -46,000, giving a free cash flow of -9.92 million.
| Operating Cash Flow | -9.88M |
| Capital Expenditures | -46,000 |
| Free Cash Flow | -9.92M |
| FCF Per Share | -0.13 |
Margins
| Gross Margin | -199.38% |
| Operating Margin | -3,282.33% |
| Pretax Margin | -7,462.16% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:ZYUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.41% |
| Shareholder Yield | -28.41% |
| Earnings Yield | -64.95% |
| FCF Yield | -19.06% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSXV:ZYUS has an Altman Z-Score of -19.21. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.21 |
| Piotroski F-Score | n/a |